Medeva takes $50M for drug money

Roper, Akil Salim
January 1999
Private Placement Letter;01/04/99, Vol. 17 Issue 1, p8
Focuses on the $50 million senior unsecured loan note financing of Medeva PLC. Information on the loan note; Details on the deal; Background information on the company.


Related Articles

  • Medeva backtracks.  // Chemical Week;7/28/1993, Vol. 153 Issue 3, p4 

    Reports on the steps taken by Medeva to restore investors' confidence after issuing a profits warning that reduced its share price by 50 percent. Acknowledging shareholders' concern on its fast-track acquisition strategy; Pre-tax profits in 1993 as below market expectations.

  • Medeva Pharmaceuticals. Rankin, Ken // Drug Store News;8/18/97, Vol. 19 Issue 13, pCP24 

    Profiles Fort Worth, Texas-based generic drug company Medeva PLC. Contact information; Financial performance; Drugs marketed.

  • Fisons and Medeva in merger talks. Young, Ian // Chemical Week;4/26/1995, Vol. 156 Issue 16, p19 

    Reports on the proposed merger of British companies Fisons and Medeva. Negotiations on the merger; Amount Fisons would have to pay for Medeva.

  • Image maker. Horton, Kathleen // Pharmaceutical Executive;Jul97, Vol. 17 Issue 7, p91 

    Reports on Medeva Pharmaceuticals' selection of Porter Novelli as its corporate public relations counsel. Porter's task of enhancing Medeva's visibility among selected health care audiences.

  • ...confirms U.S. drug sale.  // Chemical Week;6/12/1996, Vol. 158 Issue 23, p6 

    Reports on Rhone-Poulenc Rorer Inc.'s plan to sell some of the former activities of Fisons in the United States and some French pharmaceutical products to drug company Medeva PLC in United Kingdom.

  • Rochester sale.  // Drug Topics;7/8/96, Vol. 140 Issue 13, p32 

    Reports that Medeva PLC has agreed to buy the Rochester Business and a group of pharmaceutical products owned by Rhone-Poulenc Rorer.

  • Medeva still on acquisition trail.  // Chemical Week;7/26/1995, Vol. 157 Issue 3, p8 

    Reports on London, England-based Medeva's merger negotiations with Fisons. Medeva's financial performance.

  • Megamergers continue. Dorey, Emma // Nature Biotechnology;Jan2000, Vol. 18 Issue 1, p7 

    Reports on an announcement by Slough, Great Britain-based Celltech Chiroscience PLC that it will merge with Leatherhead, Great Britain-based Medeva PLC in a multi-million dollar deal. Market value of the integrated life science company; Operations of both the companies.

  • World News & Analysis. Gopal, Kevin // Pharmaceutical Executive;Dec99, Vol. 19 Issue 12, p26 

    Presents international news briefs on pharmaceutical industry. Information on the acquisition of Medeva company by Celltech Chiroscience company; Details on the deregulation of the European pharmaceutical industry; Reason for the assessment of the reimbursement rates of products for severe and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics